Efficacy and Safety of Opicapone in Clinical Practice in Parkinson's Disease Patients With Wearing-off Motor Fluctuations

Next Previous
Trial Profile

Efficacy and Safety of Opicapone in Clinical Practice in Parkinson's Disease Patients With Wearing-off Motor Fluctuations

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Mar 2018

At a glance

  • Drugs Opicapone (Primary) ; Levodopa
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms OPTIPARK
  • Sponsors Bial

    • Most Recent Events

    • 23 Mar 2018 Planned End Date changed from 1 Feb 2018 to 1 Jun 2018.
    • 23 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Jun 2018.
    • 23 Mar 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top